The spliceosome assembles on pre-mRNA in a stepwise manner through five successive 22 pre-spliceosome complexes. The spliceosome functions to remove introns from pre-mRNAs to 23 generate mature mRNAs that encode functional proteins. Many small molecule inhibitors of the 24 spliceosome have been identified and they are cytotoxic. However, little is known about the 25 mechanisms leading to cell death. Activating transcription factor 3 (ATF3) is a transcription 26 factor that can stimulate apoptotic cell death in response to a variety of cellular stresses. Here,
Introduction 34
Most protein-coding genes are transcribed into a precursor RNA (pre-mRNA) that 35 requires significant processing to produce mature mRNA. One of the more complex 36 modifications is the removal of introns and ligation of exons through the process of pre-mRNA 37 splicing. The major spliceosome is responsible for the removal of the vast majority of introns, so 38 it is usually referred to as the spliceosome [1] . The spliceosome is composed of five small nuclear 39 RNAs (snRNAs), U1, U2, U4, U5 and U6, which are each associated with specific proteins 40 yielding their corresponding small nuclear ribonuclear protein complexes (snRNPs). These 41 snRNPs bind sequentially to cis-acting elements in pre-mRNA including the 5' and 3' splice HCT116 cells were obtained from the American Tissue Type Collection (Cat #: CCL-247, 65 Manassas, VA) grown in McCoys media (Hyclone, San Angelo) supplemented with 10% Fetal 66 Calf Serum (FBS) (Gibco, Dun Laoghaire) and 90units/ml penicillin, 90ug/ml streptomycin 67 (Hyclone). ATF3 +/+ and ATF3 -/-MEFs were obtained from Dr. Jim Dimitroulakos (Ottawa 68 Hospital Research Institute) (St. Germain et al., 2010) 4˚C in primary antibody, anti-ATF-3 (sc-188, Santa Cruz, CA) or anti-beta-actin (A2228, Sigma) in 0.5% Milk in TBST pH 7.6. Membranes were washed 4x5 min in TBST, then incubated in 88 secondary antibody (HRP-conjugated goat anti-mouse or goat anti-rabbit from Abcam) for 1-2 89 hours. Membranes were washed 4x5 min in TBST, then incubated for 5 minutes in 600μl of 90 Clarity TM Western ECL substrate (Bio-Rad), and imaged using the Fusion FX5 gel Floating and adherent cells were collected together by centrifugation following trypsin treatment.
95
The supernatant was removed, and the cell pellet was washed twice in PBS, fixed in 1ml ice cold For trypan blue dye exclusion assays, cells were detached using trypsin and 10 ul of trypan blue 111 (0.4% in PBS) was added to each well of the 96-well plate. After two minutes, an aliquot of cells 112 was transferred to Dual-Chamber cell counting slides (Bio-Rad, Hercules) and read using the 113 Biorad TC20 Automated Cell Counter.
115

Results
116
Splicing inhibitors induce apoptosis and increase ATF3 117
Pre-mRNA splicing is essential for viability and pre-mRNA splicing inhibitors are 118 cytotoxic through an unknown mechanism. To start to address this, HCT116 colon cancer cells 119 were exposed to either IGG or PB and 48 hours later apoptosis was assessed by flow cytometric 120 analysis of subdiploid (subG1) DNA content ( Figs 1A and B ). Exposure to either splicing 121 inhibitor resulted in an increase in the fraction of cells with sub G 1 DNA content. ATF3 is 122 important in multiple cell death pathways [7, 11, 12] but its role in response to splicing inhibition 123 was unknown. Therefore, we measured the expression of ATF3 in response to treatment with 124 both splicing inhibitors in these cells ( Fig 1C) . ATF3 levels increased following treatment with 125 cytotoxic concentrations of both splicing inhibitors but the fold increase in ATF3 appears to be 126 greater in PB-treated cells. ATF3 contributes to cell sensitivity 138 We used a genetic approach to determine if ATF3 contributed to cell death following 139 spliceosome inhibition in isogenic MEF strains that either expressed or did not express ATF3 140 (ATF3 +/+ and ATF3 -/-MEFs, respectively). As detected in HCT116 cells, ATF3 levels increased 141 in the ATF3 +/+ MEFs in response to IGG and PB exposure (Fig 2A) . As expected, ATF3 was not 142 detected in the ATF3 -/-MEFs. We assessed sensitivity to apoptosis by one parameter flow 143 cytometric analysis of sub G 1 DNA content in both cell lines following exposure to IGG and PB 144 (Fig. 2B ). Cells deleted of ATF3 were significantly protected against the lethal affects of both 145 drugs. Therefore, PB and IGG appear to induce ATF3-dependent apoptosis in MEFs. The sensitivity of MEFs to spliceosome inhibition was further evaluated with two 157 additional independent assays. First, ATF3 +/+ and ATF3 -/-MEFs were exposed to either IGG or 158 PB for 24h and cell viability was assessed by trypan blue dye exclusion ( Fig 3A) . Trypan blue is 159 unable to penetrate viable cells with intact cell membranes, whereas non-viable cells that have 194 However, cell viability was significantly higher in ATF3-/-, as assessed in 3 independent assays.
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Subtle quantitative differences were detected among the assays that reflect the timing of 196 individual assays, the timing of changes associated with cell death and the sensitivity of 197 individual assays. Of note, CellTiter-Glo® Luminescent Cell Viability Assay is not determined 198 on a single cell basis and it is very sensitive [16] so it isn't entirely surprising that we detected 199 greater apparent cell death with this assay. Despite these differences, all three assays suggest that 200 ATF3 as a regulator of mammalian cell sensitivity to these pre-mRNA splicing inhibitors.
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The two spliceosome inhibitors tested target distinct pre-spliceosome complexes. PB 202 interacts with the SF3B1 subunit of the U2 snRNP in the complex A [5] whereas IGG acts 203 somewhat later preventing the transition from the A to B complex through an unknown target 204 [4] . Despite the fact that both drugs inhibit pre-mRNA splicing at similar stages and induce 205 apoptosis through an ATF3-dependent mechanism, a variety of differences in gene expression 206 and biological effects have been described. For example, we have previously reported that these 207 two drugs can have pronounced effects on cell cycle distribution [17] . Importantly, these drugs 208 led to similar but not identical changes in cell cycle distribution [17] . Two parameter flow 209 cytometric analysis of bromodeoxyuridine-labelled cells indicated that IGG led to multiple cell 210 cycle alterations but the most prominent was to an S phase arrest [17] . In partial contrast, PB-211 treated cells were blocked predominantly in G 1 but also exhibited a more modest S phase arrest 212 than IGG-treated cells [17] . Meanwhile, both drugs led to decreased M phase assessed by loss of 213 phospho-H3 immunoreactivity [17] . Therefore, there are similarities and differences in the 214 effects of these compounds on cell cycle responses.
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Other groups have reported recently that IGG has other unique effects on transcription 216 and protein trafficking. Boswell and coworkers found that IGG decreases transcriptional 217 elongation, independent of effects on pre-mRNA splicing [18] . Strand-specific RNA-sequencing 218 (RNA-seq) was performed in IGG-treated and control cells and relative read number increased 219 within 5 kb of transcription start sites in IGG-treated cells but not in the presence of an SF3B1 220 inhibitor, meayamycin [19] , suggesting that transcription near the 5'end of genes was slow in the 221 presence of IGG [18] . These authors also detected increased polyA site readthrough in IGG 222 treated cells further suggesting that a fundamental problem in transcription and co-transcriptional 223 processing may underlie some of the unique biological effects of IGG [18] . It is noteworthy that these authors still detected a defect in pre-mRNA splicing using RNA-seq analysis in this and 225 previous papers [18, 20] . 226 Lastly, IGG also appear to inhibit trafficking of the amyloid precursor protein (APP) 227 from endoplasmic reticulum (ER) to the Golgi [21] and lysosome-mediated turnover [22] . In the 228 former, APP levels increased in response to IGG but not the SF3B1 inhibitor spliceostatin [21] .
229
APP was retained in the ER and where the protein was stable and accumulated [21] . In the latter alter the ATF3-dependence of cell death induced by IGG and PB. It is likely that IGG and PB 239 lead to ATF3 induction through a common mechanism related to spliceosome inhibition.
241
Conclusions
242
ATF3 is involved in a variety of stress pathways, and it is likely that a disruption in 243 spliceosome formation is leading to activation of ATF3, in turn promoting apoptosis. The novel 244 findings here provide evidence that splicing inhibitors lead to activation of ATF3, and that 245 ATF3, in turn, is playing a role in determining sensitivity of cells to these compounds. Our future work will investigate the role ATF3 has on cell sensitivity, and work to determine how each of 247 these splicing inhibitors specifically led to ATF3 activation. 
